Ocuphire Pharma Total Current Assets 2010-2024 | IRD

Ocuphire Pharma total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Ocuphire Pharma Annual Total Current Assets
(Millions of US $)
2023 $54
2022 $49
2021 $26
2020 $18
2019 $2
2018 $16
2017 $28
2016 $21
2015 $25
2014 $33
2013 $19
2012 $14
2011 $12
2010 $16
2009 $8
Ocuphire Pharma Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $45
2024-03-31 $52
2023-12-31 $54
2023-09-30 $54
2023-06-30 $43
2023-03-31 $45
2022-12-31 $49
2022-09-30 $15
2022-06-30 $18
2022-03-31 $20
2021-12-31 $26
2021-09-30 $23
2021-06-30 $25
2021-03-31 $12
2020-12-31 $18
2020-09-30 $9
2020-06-30 $10
2020-03-31 $11
2019-12-31 $2
2019-09-30 $15
2019-06-30 $17
2019-03-31 $19
2018-12-31 $16
2018-09-30 $14
2018-06-30 $18
2018-03-31 $22
2017-12-31 $28
2017-09-30 $24
2017-06-30 $28
2017-03-31 $19
2016-12-31 $21
2016-09-30 $23
2016-06-30 $20
2016-03-31 $25
2015-12-31 $25
2015-09-30 $23
2015-06-30 $27
2015-03-31 $30
2014-12-31 $33
2014-09-30 $36
2014-06-30 $39
2014-03-31 $41
2013-12-31 $19
2013-09-30 $15
2013-06-30 $10
2013-03-31 $12
2012-12-31 $14
2012-09-30 $8
2012-06-30 $9
2012-03-31 $10
2011-12-31 $12
2011-09-30 $16
2011-06-30 $19
2011-03-31 $24
2010-12-31 $16
2010-09-30 $17
2010-06-30 $19
2010-03-31 $8
2009-12-31 $8
2009-09-30 $4
2009-06-30 $4
2009-03-31 $3
Sector Industry Market Cap Revenue
$0.000B $0.000B
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00